Methylprednisolone Sodium Succinate Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-258

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 63323-258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Met15 0001 01

Chemical structure of methylprednisolone sodium succinate, showing its molecular formula and components with molecular weight 496.53.*

FDA Label Image

Met15 0001 02

FDA Label Image

Met15 0001 03

Label for Methylprednisolone Sodium Succinate for Injection, USP, showing dosage strength of 40 mg per vial. Instructions include reconstitution with 1 mL bacteriostatic water for injection before use, with noted use for intravenous or intramuscular injection. The label also mentions a 1 mL single dose vial.*

FDA Label Image

Met15 0001 04

Methylprednisolone Sodium Succinate 40 mg/mL for injection, USP. The label indicates it is a 1 mL single dose vial for intravenous or intramuscular use. The product is labeled by APP Pharmaceuticals, LLC.*

FDA Label Image

Met15 0001 05

Methylprednisolone Sodium Succinate for Injection USP label showing 125 mg per vial strength. Instructions indicate reconstitution with 2 mL bacteriostatic water for injection with benzyl alcohol. The product is intended for intravenous or intramuscular use and is provided by APP Pharmaceuticals, LLC.*

FDA Label Image

Met15 0001 06

Label for Methylprednisolone Sodium Succinate for Injection, USP, showing a 125 mg per vial strength. The vial contains 2 mL for single-dose use and is intended for intravenous or intramuscular administration. The product is labeled by APP Pharmaceuticals, LLC and is prescription only.*

FDA Label Image

Met15 0001 07

Methylprednisolone Sodium Succinate for Injection, USP label showing the 1 gram per vial strength. The label states it is for intravenous or intramuscular use, contains benzyl alcohol as a preservative, and provides 8 doses of 125 mg each from a multiple-dose vial. Labeled by APP Pharmaceuticals, LLC.*

FDA Label Image

Met15 0001 08

Label for Methylprednisolone Sodium Succinate for Injection, USP, 1 gram per vial. The label states it is for intravenous or intramuscular use, contains benzyl alcohol as a preservative, and mentions doses from 8 to 125 mg. It is a multiple-dose vial labeled Rx only. The label features the Fresenius Kabi logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.